Health Care/Hospital
Duke-NUS' largest graduating cohort celebrates diverse pathways to medicine
* The largest graduating class in Duke-NUS' history saw 90 graduates, including the first-ever Master of International Translational Medicine cohort, receive their degrees * Collectively, this cohort published 99 academic publications, underscoring Duke-NUS' role as a leader in innovation and...
2024-06-01 19:00
3401
China Jo-Jo Drugstores Announces Changes to Board of Directors
HANGZHOU, China, May 31, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that Ms. P...
2024-06-01 04:30
5012
China and South Korea Fortify Economic Ties at 2nd CISCE Roadshow
SEOUL, South Korea, May 31, 2024 /PRNewswire/ -- On May 27, 2024, the 8th China -Japan-South Korea Business Summit convened inSeoul, South Korea, highlighted by a delegation led byRen Hongbin, Chairman of the China Council for the Promotion of International Trade. The program featured the China-So...
2024-05-31 23:24
4030
Hello Health Group (HHG) Welcomes 5i Ventures (5iV) as Leading Investor, Paving the Way for Future Growth
SINGAPORE, May 31, 2024 /PRNewswire/ -- Hello Health Group (HHG), the leading digital health and wellness platform inAsia, is pleased to announce the successful closing of theSingapore-based 5i Ventures (5iV) acquisition of a major stake in HHG. Following the transaction, 5iV will be the new lead...
2024-05-31 21:37
3903
GRIT and Quangang Forge Strategic Partnership to Accelerate Localization of Interleukin-2
SHANGHAI, May 31, 2024 /PRNewswire/ -- Shanghai Grit Biotechnology Co., Ltd. (GRIT) and Shandong Quangang Pharmaceutical Co., Ltd. (Quangang) announced the establishment of a formal strategic partnership to leverage both parties' R&D capabilities in innovative T-cell therapy. The objective is to ...
2024-05-31 21:16
2508
Neurophet to participate BIO USA… exploring global partnership and business
* Neurophet's AI brain image analysis technology improves time and cost efficiency for drug development * Aims to create business opportunities with global pharmaceutical companies SEOUL, South Korea, May 31, 2024 /PRNewswire/ -- Neurophet, an artificial intelligence (AI) solution company for...
2024-05-31 21:00
2641
Vieworks Showcases Innovative X-ray Imaging Solutions at WCNDT (World Conference on Non-Destructive Testing) 2024
ANYANG, South Korea, May 31, 2024 /PRNewswire/ -- Vieworks, a leading innovator in x-ray imaging solution, recently marked a significant milestone by participating in the 21st World Conference on Non-Destructive Testing (WCNDT) for the first time. Held in Songdo,South Korea, WCNDT 2024 served as ...
2024-05-31 15:44
2018
SIFI receives positive CHMP opinion for AKANTIOR® (polihexanide 0.08%) in acanthamoeba keratitis
ACI SANT'ANTONIO, Italy, May 31, 2024 /PRNewswire/ -- SIFI announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of AKANTIOR® (polihexanide under the international non-proprietary name),...
2024-05-31 15:00
1591
Clarivate Expands Real-World Data Offering with Addition of Social Determinant of Health (SDoH) Attributes from HealthWise Data
Strategic collaboration enhances insight into patient demographics and behaviors, enabling analytical precision in addressing population health outcomes LONDON, May 31, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a str...
2024-05-31 15:00
1606
Announcement of change in the total number of votes in AB SKF
GOTHENBURG, Sweden, May 31, 2024 /PRNewswire/ -- Due to a conversion of shares from Series A to Series B in accordance with AB SKF's Articles of Association, the Company confirms the following. As per 31 May 2024, the Company's share capital amounts to SEK 1,138,377,670 and the total number of s...
2024-05-31 14:45
1543
Oy Apotti Ab Partners with uPerform to Enhance EHR Education and Support
Apotti pioneers Finnish collaboration with uPerform to scale its EHR education program and optimize support. ELKRIDGE, Md., May 31, 2024 /PRNewswire/ -- Oy Apotti Ab (Apotti) based in Helsinki, Finland, deployed a just-in-time learning platform for its Epic® -based Electronic Health Record (EHR) ...
2024-05-31 12:00
1530
Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom
Domestic and international markets in Asia surging as CPHI & PMEC China
welcomes 60,000 attendees and 3500 exhibitors
SHANGHAI and AMSTERDAM, May 31, 2024 /PRNewswire/ -- CPHI & PMEC China
2024-05-31 11:18
1792
One in Six Globally Concerned About Colorectal Cancer Screening Costs
SHENZHEN, China, May 31, 2024 /PRNewswire/ -- By 2040, the burden of colorectal
cancer (CRC) is projected to increase to 3.2 million new cases and 1.6 million
deaths per year representing a 66% and 71% rise in new cases and deaths
respectively relative to2020
2024-05-31 08:00
2619
Telix Announces Positive rPFS Data from ProstACT SELECT Trial of TLX591 rADC Therapy Candidate in Prostate Cancer
* TLX591 is an investigational anti-PSMA[1] radio-antibody-drug conjugate (rADC) therapy being developed for the treatment of mCRPC, differentiated by a short two-week dosing regimen. * Reported median radiographic progression-free survival (rPFS) is 8.8 months. * Builds on prior data from th...
2024-05-31 07:19
2028
LumaCina announces availability of Oral Morphine pain medication for New Zealanders
PERTH, Australia and MIAMI, May 31, 2024 /PRNewswire/ -- LumaCina, the pharmaceutical supplier and marketing division ofBridgewest Perth Pharma announce new production of Oral Morphine to meet critical drug shortage inNew Zealand. The shortfall of Oral Morphine has become increasingly concerning...
2024-05-31 05:17
1890
Ivonescimab Monotherapy Decisively Beats Pembrolizumab Monotherapy Head-to-Head, Achieves Statistically Significant Superiority in PFS in First-Line Treatment of Patients with PD-L1 Positive NSCLC
* Monotherapy Ivonescimab Achieved Clinically Meaningful PFS Benefit in HARMONi-2 Trial Conducted by Akeso * PFS Improvement Was Observed Broadly in Patients Across Subgroups, including PD-L1 Low and PD-L1 High Expressing Tumors, Squamous and Non-Squamous Histologies * Full Data Set to be P...
2024-05-31 02:21
1957
SOPHiA GENETICS Launches Global Consortium, SOPHiA UNITY, to Accelerate Cancer Research, Drug Development, and Data-Driven Patient Care
New collective intelligence network to enable the most advanced research in oncology in support of precision medicine BOSTON and ROLLE, Switzerland, May 30, 2024 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medici...
2024-05-31 01:18
1715
"Disrupt" introduces Disrupt Health Impact Fund with leading business groups in Thailand to invest in HealthTech startups globally
BANGKOK, May 30, 2024 /PRNewswire/ -- Disrupt Technology Venture ("Disrupt") announced the introduction of Disrupt Health Impact Fund with the first group of co-investment partners from leading Thai business companies – Digital Health Ventures ("DHV"), the innovation and venture arm of Samitivej ...
2024-05-30 21:52
2422
TOOsonix receives MDR CE Mark for its new oncology and dermatology device
The EU Medical Device Regulation CE certification approves that the most common types of skin cancer and a wide range of skin diseases and conditions can be treated in less than 90 seconds. COPENHAGEN, Denmark, May 30, 2024 /PRNewswire/ -- TOOsonix A/S, a pioneer in high-intensity focused ultras...
2024-05-30 21:23
1451
Teikoku Pharma USA, Inc. Announces NMPA Approved Lidoderm® in China on May 8, 2024
SAN JOSE, Calif., May 30, 2024 /PRNewswire/ -- Teikoku Pharma USA (TPU) announced today that the NMPA (National Medical Products Administration) has approved Lidoderm® ("lidocaine 5% patch as lidocaine cataplasms") for the treatment of Post Herpetic Neuralgia (PHN) inChina. TPU entered into an e...
2024-05-30 21:15
1444
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 301 media titles]
2024-11-26 18:49Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 288 media titles]
2024-11-28 17:24TAILG's First Flagship Store in Indonesia Grandly Opens
[Picked up by 283 media titles]
2024-11-22 21:59
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Chinese path to modernization a model for Global South, experts say
2024-11-23 15:35
11468
SUNLU Formnext 2024 Event Highlights: From Functional Filaments to FilaDryer E2
2024-11-23 21:00
7513
Innovative technology and applications recognised with Hong Kong ICT Awards 2024
2024-11-23 02:02
7247
MMA SMARTIES Thailand 2024 - Celebrates Unparalleled Marketing Innovation and Excellence in Thailand
2024-11-23 11:00
6613
WeBank Powers Fusion Bank's Rapid Launch of a Next-Generation Core Banking System
2024-11-22 15:21
4964